{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:18:48Z","timestamp":1771600728511,"version":"3.50.1"},"reference-count":33,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100003417","name":"German Social Accident Insurance","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003417","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,8,9]]},"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Mesothelin and calretinin are blood-based markers for malignant mesothelioma. The objective of this study was to analyse the markers in plasma samples from cancer-free men and to identify factors influencing their concentrations to minimise false-positive test results when using these markers for the early detection of malignant mesothelioma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>The present analyses used data and archived blood samples of the population-based Heinz Nixdorf Recall Study among elderly people collected from 2011 to 2014.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>A total of 569 men (median age 70\u2009years) without a malignant disease at the time of blood sampling were selected for these analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Primary and secondary outcome<\/jats:title>\n                  <jats:p>Mesothelin and calretinin concentration in plasma samples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We observed 24 mesothelin concentrations \u22651.5\u2009nM (specificity 95.8%, 95%\u2009CI 93.8% to 97.2%) and 34 calretinin concentrations \u22651.0\u2009ng\/mL (specificity 94.0%, 95%\u2009CI 91.7% to 95.7%). Only five men had both markers above these cut-offs. Renal dysfunction and hypertension were major predictors of elevated mesothelin in addition to age. Regarding calretinin, the effect of renal dysfunction was slightly weaker and hypertension was not associated with increased concentrations. However, a diagnosis of cancer after blood collection and bronchial asthma were associated with positive calretinin results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The combined determination of mesothelin and calretinin results in only few false-positive marker tests. Both markers are mainly influenced by renal dysfunction. The determination of cystatin C concentrations may be informative when interpreting the test results.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-017104","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T01:55:26Z","timestamp":1507773326000},"page":"e017104","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study"],"prefix":"10.1136","volume":"7","author":[{"given":"Swaantje","family":"Casjens","sequence":"first","affiliation":[{"name":"Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Ruhr-Universit\u00e4t Bochum (IPA), Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G","family":"Weber","sequence":"additional","affiliation":[{"name":"Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Ruhr-Universit\u00e4t Bochum (IPA), Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Johnen","sequence":"additional","affiliation":[{"name":"Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Ruhr-Universit\u00e4t Bochum (IPA), Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Raiko","sequence":"additional","affiliation":[{"name":"Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Ruhr-Universit\u00e4t Bochum (IPA), Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Taeger","sequence":"additional","affiliation":[{"name":"Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Ruhr-Universit\u00e4t Bochum (IPA), Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Meinig","sequence":"additional","affiliation":[{"name":"Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Ruhr-Universit\u00e4t Bochum (IPA), Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Moebus","sequence":"additional","affiliation":[{"name":"Institute of Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"J\u00f6ckel","sequence":"additional","affiliation":[{"name":"Institute of Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[{"name":"Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Ruhr-Universit\u00e4t Bochum (IPA), Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Pesch","sequence":"additional","affiliation":[{"name":"Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Ruhr-Universit\u00e4t Bochum (IPA), Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"2025101811352783000_7.10.e017104.1","first-page":"491","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"2025101811352783000_7.10.e017104.2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","article-title":"The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050","volume":"92","author":"Hodgson","year":"2005","journal-title":"Br J Cancer"},{"key":"2025101811352783000_7.10.e017104.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004145","article-title":"Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis","volume":"4","author":"Cui","year":"2014","journal-title":"BMJ Open"},{"key":"2025101811352783000_7.10.e017104.4","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e31829b6fbd"},{"key":"2025101811352783000_7.10.e017104.5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-242"},{"key":"2025101811352783000_7.10.e017104.6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12885-017-3375-5","article-title":"Calretinin as a blood-based biomarker for mesothelioma","volume":"17","author":"Johnen","year":"2017","journal-title":"BMC Cancer"},{"key":"2025101811352783000_7.10.e017104.7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bbapap.2013.12.007","article-title":"Biomarker research with prospective study designs for the early detection of cancer","volume":"1844","author":"Pesch","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2025101811352783000_7.10.e017104.8","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.079327"},{"key":"2025101811352783000_7.10.e017104.9","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.121913"},{"key":"2025101811352783000_7.10.e017104.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/BMI.S3927","article-title":"Assessment of confounding factors affecting the tumor markers SMRP, CA125, and CYFRA21-1 in serum","volume":"5","author":"Weber","year":"2010","journal-title":"Biomark Insights"},{"key":"2025101811352783000_7.10.e017104.11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuro.2016.11.005","article-title":"Associations between former exposure to manganese and olfaction in an elderly population: results from the heinz nixdorf recall study","volume":"58","author":"Casjens","year":"2017","journal-title":"Neurotoxicology"},{"key":"2025101811352783000_7.10.e017104.12","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.123579"},{"key":"2025101811352783000_7.10.e017104.13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/CBM-2007-3602","article-title":"Soluble mesothelin-related peptides (SMRP) - high stability of a potential tumor marker for mesothelioma","volume":"3","author":"Weber","year":"2007","journal-title":"Cancer Biomark"},{"key":"2025101811352783000_7.10.e017104.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1697-1"},{"key":"2025101811352783000_7.10.e017104.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6"},{"key":"2025101811352783000_7.10.e017104.16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.ejso.2017.02.010","article-title":"Is less also better? A single-institution experience on treatment of early stage Malignant Pleural Mesothelioma","volume":"43","author":"Bertoglio","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"2025101811352783000_7.10.e017104.17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.21037\/tlcr.2017.05.02","article-title":"Immunotherapy for malignant pleural mesothelioma: current status and future directions","volume":"6","author":"Dozier","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"2025101811352783000_7.10.e017104.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00319-2017"},{"key":"2025101811352783000_7.10.e017104.19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.21037\/tlcr.2017.06.03","article-title":"Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma","volume":"6","author":"Wu","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"2025101811352783000_7.10.e017104.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013324","article-title":"Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study","volume":"6","author":"Tsim","year":"2016","journal-title":"BMJ Open"},{"key":"2025101811352783000_7.10.e017104.21","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318275b346"},{"key":"2025101811352783000_7.10.e017104.22","first-page":"97","article-title":"Incidence of malignant mesothelioma in Germany 2009-2013","volume":"28","author":"Lehnert","year":"2017","journal-title":"Cancer Causes Control"},{"key":"2025101811352783000_7.10.e017104.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2010.04.110"},{"key":"2025101811352783000_7.10.e017104.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2004.09.025"},{"key":"2025101811352783000_7.10.e017104.25","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2010.482214"},{"key":"2025101811352783000_7.10.e017104.26","doi-asserted-by":"publisher","DOI":"10.5414\/CNP74039"},{"key":"2025101811352783000_7.10.e017104.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-013-1669-6"},{"key":"2025101811352783000_7.10.e017104.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2007.07.042"},{"key":"2025101811352783000_7.10.e017104.29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00420-013-0853-1","article-title":"Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers","volume":"87","author":"Felten","year":"2014","journal-title":"Int Arch Occup Environ Health"},{"key":"2025101811352783000_7.10.e017104.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14794-0"},{"key":"2025101811352783000_7.10.e017104.31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200811-1729OC"},{"key":"2025101811352783000_7.10.e017104.32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/1471-2407-14-854","article-title":"Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study","volume":"14","author":"Bonberg","year":"2014","journal-title":"BMC Cancer"},{"key":"2025101811352783000_7.10.e017104.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/681416","article-title":"Serial patterns of ovarian cancer biomarkers in a prediagnosis longitudinal dataset","volume":"2015","author":"Blyuss","year":"2015","journal-title":"Biomed Res Int"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-017104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:35:33Z","timestamp":1760812533000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-017104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,11]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/bmjopen-2017-017104"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-017104","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}